Literature DB >> 10380839

Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus.

N Maeda1, I Sekigawa, N Iida, M Matsumoto, H Hashimoto, S Hirose.   

Abstract

We investigated the relationship between the ratio of CD4+ to CD8+ T cells (CD4/CD8 ratio) and T cell activation, indicated by human leukocyte antigen (HLA)-DR expression, in patients with systemic lupus erythematosus (SLE). We found that the ratio was decreased in SLE patients and that this was significantly related to expression of HLA-DR by CD8+ (but not CD4+) T cells. These findings may assist in understanding the pathogenesis of SLE. In some SLE patients, the CD4/CD8 ratio and HLA-DR expression may be good indicators of therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380839     DOI: 10.1080/03009749950154248

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  17 in total

1.  Accurate Machine Learning Model to Diagnose Chronic Autoimmune Diseases Utilizing Information From B Cells and Monocytes.

Authors:  Yuanchen Ma; Jieying Chen; Tao Wang; Liting Zhang; Xinhao Xu; Yuxuan Qiu; Andy Peng Xiang; Weijun Huang
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

2.  TRAIL death receptor-4, decoy receptor-1 and decoy receptor-2 expression on CD8+ T cells correlate with the disease severity in patients with rheumatoid arthritis.

Authors:  Atil Bisgin; Ender Terzioglu; Cigdem Aydin; Burcak Yoldas; Veli Yazisiz; Nilufer Balci; Huseyin Bagci; Reginald M Gorczynski; Cezmi A Akdis; Salih Sanlioglu
Journal:  BMC Musculoskelet Disord       Date:  2010-08-27       Impact factor: 2.362

3.  Serendipitous evidence of T lymphocyte activation in close female relatives of patients with systemic lupus erythematosus.

Authors:  M R J Green; A S M Kennell; M J Larche; M H Seifert; D A Isenberg; M R Salaman
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

4.  Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus.

Authors:  Toshio Naito; Hitoshi Ogasawara; Hiroshi Kaneko; Takashi Hishikawa; Iwao Sekigawa; Hiroshi Hashimoto; Naoki Maruyama
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

5.  The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.

Authors:  Ruth Fritsch-Stork; Daniela Müllegger; Karl Skriner; Beatrice Jahn-Schmid; Josef S Smolen; Günter Steiner
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

6.  The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers.

Authors:  Katharina Kopetschke; Jan Klocke; Anna-Sophie Grießbach; Jens Y Humrich; Robert Biesen; Duska Dragun; Gerd-Rüdiger Burmester; Philipp Enghard; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2015-04-03       Impact factor: 5.156

7.  Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.

Authors:  Li-jun Song; Xiao Wang; Xu-ping Wang; Dong Li; Feng Ding; Hua-xiang Liu; Xiao Yu; Xing-fu Li; Qiang Shu
Journal:  Diagn Pathol       Date:  2015-06-16       Impact factor: 2.644

8.  Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients.

Authors:  Junwei Chen; Lijuan Ding; Wu Meng; Jinhua Yang; Chenglan Yan; Jianfang Xie; Luo Jing; Xiaofeng Li; Zili Fu
Journal:  Med Sci Monit       Date:  2015-02-16

9.  Concurrent Kimura disease and lupus nephritis: A case report.

Authors:  Haitao Wang; Fang Fang; Ying Sun; Songlan Wang; Yonghui Mao
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

10.  Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by Lactobacillus plantarum.

Authors:  Wen-Tao Yang; Shao-Hua Shi; Gui-Lian Yang; Yan-Long Jiang; Liang Zhao; Yu Li; Chun-Feng Wang
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.